3rd Annual Neuroscience in Intensive Care International Symposium (NICIS-America)

3rd Annual Neuroscience in Intensive Care International Symposium (NICIS-America) is organized by Kenes Group and will be held from Mar 08 - 09, 2019 at Hilton Garden Inn Reagan National Airport, Arlington, Virginia, United States of America. This CME Conference has been approved for a maximum of 15 AMA PRA Category 1 CreditsTM.

Conference Description:
Neurologic biomarkers are quantifiable biological signatures identified in molecular assays of blood or CSF, neurophysiological recordings, and structural or functional changes captured with neuroimaging. Biomarkers are the basis for neurologic injury detection, diagnostic classification, treatment selection, and prognostication. In the intensive care unit, the care of patients with acute brain injury is increasingly reliant on the analysis of appropriately selected biomarkers. The conference will include sessions on physiological biomarkers, cellular biomarkers, imaging biomarkers, and biomarkers derived from high throughput molecular sequencing. Additional sessions will focus on the role of biomarkers in detection and diagnosis, treatment selection, biomarkers of impending neurological crises, and biomarkers for recovery and prognostication. The keynote speakers include Maiken Nedergard, a pioneering neuroscientist who has discovered the ‘glymphatic system’ in the brain, as well as Ramon Diaz-Arrastia, one of the principal investigators of the Track-TBI study and an internationally recognized investigator traumatic brain injury.

Why Attend:
Participants in the conference will have the opportunity to engage with world class investigators to discuss the science and practical applications of neurologic biomarkers in critical illness, neurologic injury and recovery. They will learn about the different types of neurologic biomarkers of relevance in critical care medicine, neurocritical care and cerebrovascular neurology, and how these biomarkers are derived and validated. Most importantly, they will discover how biomarker research is having a direct impact on clinical care via greater precision in diagnosis, treatment selection, and outcome prediction.

Abstract Submission Deadline - 04 January 2019
Early Bird Registration Deadline - 21 January 2019
Regular Registration Deadline - 7 March 2019

Time: 8:30 am - 5:00 pm